全文获取类型
收费全文 | 173504篇 |
免费 | 17370篇 |
国内免费 | 5759篇 |
专业分类
耳鼻咽喉 | 1480篇 |
儿科学 | 2944篇 |
妇产科学 | 1998篇 |
基础医学 | 35564篇 |
口腔科学 | 3939篇 |
临床医学 | 11487篇 |
内科学 | 26421篇 |
皮肤病学 | 3662篇 |
神经病学 | 15283篇 |
特种医学 | 3891篇 |
外国民族医学 | 53篇 |
外科学 | 14223篇 |
综合类 | 19423篇 |
现状与发展 | 26篇 |
预防医学 | 6843篇 |
眼科学 | 1936篇 |
药学 | 24544篇 |
36篇 | |
中国医学 | 6136篇 |
肿瘤学 | 16744篇 |
出版年
2024年 | 306篇 |
2023年 | 2787篇 |
2022年 | 4102篇 |
2021年 | 7512篇 |
2020年 | 6306篇 |
2019年 | 6913篇 |
2018年 | 6797篇 |
2017年 | 6760篇 |
2016年 | 6262篇 |
2015年 | 7331篇 |
2014年 | 10482篇 |
2013年 | 11359篇 |
2012年 | 9875篇 |
2011年 | 11916篇 |
2010年 | 9664篇 |
2009年 | 9824篇 |
2008年 | 9401篇 |
2007年 | 8323篇 |
2006年 | 7355篇 |
2005年 | 6466篇 |
2004年 | 5730篇 |
2003年 | 4971篇 |
2002年 | 3849篇 |
2001年 | 3161篇 |
2000年 | 2745篇 |
1999年 | 2422篇 |
1998年 | 2274篇 |
1997年 | 2108篇 |
1996年 | 1938篇 |
1995年 | 1851篇 |
1994年 | 1609篇 |
1993年 | 1413篇 |
1992年 | 1120篇 |
1991年 | 1016篇 |
1990年 | 854篇 |
1989年 | 706篇 |
1988年 | 639篇 |
1987年 | 620篇 |
1986年 | 716篇 |
1985年 | 1063篇 |
1984年 | 1108篇 |
1983年 | 805篇 |
1982年 | 825篇 |
1981年 | 690篇 |
1980年 | 609篇 |
1979年 | 503篇 |
1978年 | 339篇 |
1977年 | 287篇 |
1976年 | 301篇 |
1975年 | 206篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
101.
102.
白细胞介素4(IL-4)是T辅助2(Th2)介导的免疫反应的基本免疫调节细胞因子,IL-4具有复杂的信号系统和多效的功能,但在脑组织中,诸多研究发现IL-4可在炎症中保护认知功能。该文总结了关于IL-4保护认知功能的证据及机制,以及在阿尔茨海默病、缺血性脑血管病以及手术后认知功能障碍中IL-4保护认知功能的途径及证据。 相似文献
103.
104.
《Journal of vascular and interventional radiology : JVIR》2020,31(5):760-768.e1
PurposeTo investigate dynamic variables obtained from retrospective computed tomography angiography for ability to predict thoracic endovascular aortic repair (TEVAR) outcomes in patients with complicated type B aortic dissection (cTBAD).Materials and MethodsSeventy-nine patients with cTBAD who received TEVAR from March 2009 to June 2018 were retrospectively enrolled. Relative true lumen area (r-TLA) was computed at the level of tracheal bifurcation every 5% of all R-R intervals. Parameters that reflect the state of intimal motion were evaluated, including difference between maximum and minimum r-TLA (D-TLA) and true lumen collapse. The endpoints comprised early (≤ 30 days) and late (> 30 days) outcomes after intervention.ResultsOverall early mortality rate was 13.9% (11/79), and early adverse events rate was 24.1% (19/79). Patients who received TEVAR within 2 days of symptom onset demonstrated the worst outcomes. A longer time of r-TLA < 25% in 1 cardiac cycle (P = .049) and larger D-TLA (P < .001) were correlated to an increased early death. In addition, D-TLA was an independent predictor of early mortality. Area under the curve of D-TLA was 0.849 (95% confidence interval 0.730–0.967) for predicting early mortality and 0.742 (95% CI 0.611–0.873) for predicting early adverse events. Survival and event-free survival rates during follow-up were decreased in the D-TLA > 21.5% group compared with the D-TLA ≤ 21.5% group (all P < .001).ConclusionsLarger D-TLA is correlated with worse postoperative outcomes and might be a crucial parameter for future risk stratification in patients with cTBAD. 相似文献
105.
《Clinical therapeutics》2019,41(5):836-847
PurposeA role for the immune system in causing myalgic encephalopathy/chronic fatigue syndrome (ME/CFS) is long suspected, but few studies have looked for specific autoantibodies that might contribute to the symptoms. Our aim was to look for evidence of antibodies to neuronal proteins in patients with ME/CSF.MethodsSera samples from 50 patients and 50 healthy individuals were sent coded to the Neuroimmunology Laboratory in Oxford. Screening for antibody binding to neuronal tissue was performed on brain tissue and neuronal cultures. Specific serum antibodies were assessed by antigen-specific cell-based assays and radioimmunoassays. After antibody testing, the associations between seropositive status and clinical data were investigated.FindingsOverall, 8 patients and 11 participants were found to have some serum immunoreactivity toward neuronal or neuromuscular junction proteins, but only 1 patient and 2 participants had specific serum antibodies. Nevertheless, seropositive status in patients with ME was associated with shorter duration since onset and a more severe disease.ImplicationsThe results indicate no overall increased frequency of antibodies to neuronal proteins in ME/CSF and no evidence of a specific antibody that might be causative or contribute to clinical features in patients. However, the association of seropositive status with shorter duration of disease and more severe symptoms suggests a possible role of antibodies at onset in some patients and should be the focus of future studies. 相似文献
106.
107.
108.
《药学学报(英文版)》2020,10(7):1294-1308
A great challenge in multi-targeting drug discovery is to identify drug-like lead compounds with therapeutic advantages over single target inhibitors and drug combinations. Inspired by our previous efforts in designing antitumor evodiamine derivatives, herein selective histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) dual inhibitors were successfully identified, which showed potent in vitro and in vivo antitumor potency. Particularly, compound 30a was orally active and possessed excellent in vivo antitumor activity in the HCT116 xenograft model (TGI = 75.2%, 150 mg/kg, p.o.) without significant toxicity, which was more potent than HDAC inhibitor vorinostat, TOP inhibitor evodiamine and their combination. Taken together, this study highlights the therapeutic advantages of evodiamine-based HDAC1/TOP2 dual inhibitors and provides valuable leads for the development of novel multi-targeting antitumor agents. 相似文献
109.
110.
The specific role of postsynaptic activity for the generation of a functional magnetic resonance imaging (fMRI) response was determined by a simultaneous measurement of generated field excitatory postsynaptic potentials (fEPSPs) and blood oxygen level-dependent (BOLD) response in the rat hippocampal CA1 region during electrical stimulation of the contralateral CA3 region. The stimulation electrode was placed either in the left CA3a/b or CA3c, causing the preferentially basal or apical dendrites of the pyramidal cells in the right CA1 to be activated. Consecutive stimulations with low-intensity stimulation trains (i.e., 16 pulses for 8 seconds) resulted in clear postsynaptic responses of CA1 pyramidal cells, but in no significant BOLD responses. In contrast, consecutive high-intensity stimulation trains resulted in stronger postsynaptic responses that came along with minor (during stimulation of the left CA3a/b) or substantial (during stimulation of the left CA3c) spiking activity of the CA1 pyramidal cells, and resulted in the generation of significant BOLD responses in the left and right hippocampus. Correlating the electrophysiologic parameters of CA1 pyramidal cell activity (fEPSP and spiking activity) with the resultant BOLD response revealed no positive correlation. Consequently, postsynaptic activity of pyramidal cells, the most abundant neurons in the CA1, is not directly linked to the measured BOLD response. 相似文献